The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo

This publication has 58 references indexed in Scilit:

• Early repolarization in mice causes overestimation of ventricular activation time by the QRS duration
  Cardiovascular Research, 2012
• Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation
  Frontiers in Pharmacology, 2012
• Intraventricular Conduction Delay in a Standard 12-Lead Electrocardiogram as a Predictor of Mortality in the General Population
  Circulation: Arrhythmia and Electrophysiology, 2011
• Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart
  PLOS ONE, 2011
• Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4
  Proceedings of the National Academy of Sciences, 2011
• Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
  EP Europace, 2010
• In vivo studies of Scn5a+/− mice modeling Brugada syndrome demonstrate both conduction and repolarization abnormalities
  Journal of Electrocardiology, 2010
• Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure
  American Journal of Physiology-Heart and Circulatory Physiology, 2009
• ON THE MECHANISM OF CARBAMAZEPIN-INDUCED ANTINOCICEPTION IN THE FORMALIN TEST
  International Journal of Neuroscience, 2006
• Novel If Current Inhibitor Ivabradine: Safety Considerations
  2006